2015
Outcomes of resected pancreatic cancer in patients age ≥70
Hayman T, Strom T, Springett G, Balducci L, Hoffe S, Meredith K, Hodul P, Malafa M, Shridhar R. Outcomes of resected pancreatic cancer in patients age ≥70. Journal Of Gastrointestinal Oncology 2015, 6: 498-504. PMID: 26487943, PMCID: PMC4570916, DOI: 10.3978/j.issn.2078-6891.2015.038.Peer-Reviewed Original ResearchOutcomes of patientsAdjuvant chemoradiationOverall survivalCA19-9Patient agePancreatic cancerMultivariate analysisMedian patient ageUpfront surgical resectionPancreatic cancer patientsNeoadjuvant therapyPrimary endpointNodal statusSurgical resectionYounger patientsYear OSCancer patientsPancreatic carcinomaPatientsChemoradiationMortalitySignificant correlationOutcomesCancerMonths
2010
3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer
Chuong M, Hayman T, Patel M, Russell M, Malafa M, Hodul P, Springett G, Shridhar R, Hoffe S, Choi J. 3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s301. DOI: 10.1016/j.ijrobp.2010.07.715.Peer-Reviewed Original Research